Style | Citing Format |
---|---|
MLA | Salemi F, et al.. "Neuroblastoma: Essential Genetic Pathways and Current Therapeutic Options." European Journal of Pharmacology, vol. 926, no. , 2022, pp. -. |
APA | Salemi F, Alam W, Hassani MS, Hashemi SZ, Jafari AA, Mirmoeeni SMS, Arbab M, Mortazavizadeh SMR, Khan H (2022). Neuroblastoma: Essential Genetic Pathways and Current Therapeutic Options. European Journal of Pharmacology, 926(), -. |
Chicago | Salemi F, Alam W, Hassani MS, Hashemi SZ, Jafari AA, Mirmoeeni SMS, Arbab M, Mortazavizadeh SMR, Khan H. "Neuroblastoma: Essential Genetic Pathways and Current Therapeutic Options." European Journal of Pharmacology 926, no. (2022): -. |
Harvard | Salemi F et al. (2022) 'Neuroblastoma: Essential Genetic Pathways and Current Therapeutic Options', European Journal of Pharmacology, 926(), pp. -. |
Vancouver | Salemi F, Alam W, Hassani MS, Hashemi SZ, Jafari AA, Mirmoeeni SMS, et al.. Neuroblastoma: Essential Genetic Pathways and Current Therapeutic Options. European Journal of Pharmacology. 2022;926():-. |
BibTex | @article{ author = {Salemi F and Alam W and Hassani MS and Hashemi SZ and Jafari AA and Mirmoeeni SMS and Arbab M and Mortazavizadeh SMR and Khan H}, title = {Neuroblastoma: Essential Genetic Pathways and Current Therapeutic Options}, journal = {European Journal of Pharmacology}, volume = {926}, number = {}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Salemi F AU - Alam W AU - Hassani MS AU - Hashemi SZ AU - Jafari AA AU - Mirmoeeni SMS AU - Arbab M AU - Mortazavizadeh SMR AU - Khan H TI - Neuroblastoma: Essential Genetic Pathways and Current Therapeutic Options JO - European Journal of Pharmacology VL - 926 IS - SP - EP - PY - 2022 ER - |